Efficacy and safety of endoscopic submucosal dissection in the treatment of early cardia cancer and non-cardia cancer with submucosal infiltration
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 1
Abstract
"<b>Objective</b> To analyze the clinicopathological features of submucosal early cardia and non-cardia cancer,and evaluate the efficacy of endoscopic submucosal dissection (ESD) for treating early gastric cancer (EGC) with submucosal infiltration. <b>Methods</b> The clinical data of EGC patients with submucosal infiltration who received ESD in Nanjing Drum Tower Hospital from January 2014 to December 2019 were retrospectively analyzed, including 202 cases of cardia cancer (206 lesions) and 112 cases of non-cardia cancer (119 lesions). The basic data, pathological features, short-term and long-term prognosis of the two groups were compared. <b>Results</b> Compared with non-cardia cancer group, in cardia cancer group,the patients had older age and a lower proportion of gastric cancer family history (P<0.05), and higher proportions of concave lesion appearance, infiltration depth achieved SM2 (depth of submucasal infiltration>500μm), moderate-to-severe atrophic gastritis and deep cystic gastritis (P<0.05). There was no significant difference in complete resection rate (82.04%vs 81.51%,χ2 0.014,P=0.906), curative resection rate (38.83%vs 42.02%,χ2 0.318,P=0.573) between cardia cancer group and non-cardia cancer group, but the incidences of positive vertical margin, en bloc resection and postoperative stenosis of cardia cancer group were higher (P<0.05). The postoperative bleeding rate was 3.96% in cardia cancer group and 5.36% in non-cardia cancer group, and no perforation occurred in either group. The incidences of synchronous cancer, metachronous cancer, lymph node metastasis and distant metastasis after ESD in the two groups were low, and no statistical difference was found (P>0.05). Follow-up to July 15, 2020, except for the lost cases, the overall survival rate (95.31%vs 97.20%) and disease-specific survival rate (97.92%vs 97.20%) were all high in cardia cancer and non-cardiac cancer groups,and showed no statistically significant difference between two groups (P>0.05). <b>Conclusion</b> Early-stage cardia cancer and non-cardia cancer with submucosal infiltration exhibit different clinicopathological features. ESD is an effective treatment for the two, due to its high complete resection rate, few surgical complications, and low postoperative recurrence and metastasis rates."
Authors and Affiliations
ZHU Tingting, REN Ximei, YANG Jinping, LI Wenjun, XIANG Ying, XU Guifang
Correlation study between insulin resistance index and non-alcoholic fatty liver disease
Objective To explore the relationship between homeostasis model assessment of insulin resistance index (HOMA-IR) and non-alcoholic fatty liver disease (NAFLD). Methods The registered participants aged 18 years or older i...
Progress on the impact of lipid metabolism reprogramming on resistance to epidermal growth factor receptor tyrosine kinase inhibitors in nonsmall cell lung cancer
Non-small cell lung cancer (NSCLC) is the main type of lung cancer, accounting for 85% to 90% of cases. The use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has greatly improved the prognosi...
Efficacy of autologous platelet-rich plasma intradiscal injection in the treatment of discogenic low back pain
<b>Objective</b> To investigate the efficacy of intradiscal injection of autologous platelet-rich plasma (PRP) in the treatment of discogenic low back pain (DLBP). b>Methods</b> A retrospective analysis of clinical dat...
Research progress of gene detection in systemic therapy of pancreatic cancer
Pancreatic cancer is a common highly malignant digestive tract tumor. Due to its location and disease characteristics, it presents significant challenges in treatment. The molecular diversity of pancreatic cancer contrib...
Correlation between triglyceride-glucose index and atherosclerosis in type 2 diabetes mellitus
Objective To investigate the the clinical application of triglyceride-glucose (TyG) index and its correlation with atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Methods From January 2020 to December...